TF and Parkinson disease: In any case, the data obtained in this study from PD patients and MPTP-treated mice suggest that the increased α-2-macroglobulin activity in the TF can be considered as a potential diagnostic biomarker for both clinical and preclinical stages of PD (Table 3).